Indication
Acute Pseudomonas aeruginosa pneumonia associated with cystic fibrosis
Acute *Pseudomonas aeruginosa* pneumonia associated with cystic fibrosis refers to a severe lower respiratory tract infection caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa* in individuals with the genetic disorder cystic fibrosis. Read more about Acute Pseudomonas aeruginosa pneumonia associated with cystic fibrosis
22 drugs 13 manufacturers
Drugs that treat it
Common Acute Pseudomonas aeruginosa pneumonia associated with cystic fibrosis therapies.
TAZICEF (ceftazidime)
TAZICEF (ceftazidime)
FORTAZ (ceftazidime)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute *Pseudomonas aeruginosa* pneumonia associated with cystic fibrosis refers to a severe lower respiratory tract infection caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa* in individuals with the genetic disorder cystic fibrosis.
In this population, defective cystic fibrosis transmembrane conductance regulator (CFTR) function results in dehydrated, viscous airway secretions and impaired mucociliary clearance, creating an ideal niche for rapid bacterial proliferation and invasive parenchymal inflammation.
Clinically, it manifests as an acute pulmonary exacerbation marked by sudden clinical decline, increased cough, changes in sputum production or purulence, tachypnea, dyspnea, and systemic signs such as fever and weight loss.
Pathophysiologically, the infection induces intense neutrophilic inflammation, tissue destruction, and alveolar consolidation, which can precipitate respiratory failure and accelerate progressive irreversible loss of lung function.
- cff.org
Acute *Pseudomonas aeruginosa* pneumonia associated with cystic fibrosis refers to a severe lower respiratory tract infection caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa* in individuals with the genetic disorder cystic fibrosis
- frontiersin.org
Acute *Pseudomonas aeruginosa* pneumonia associated with cystic fibrosis refers to a severe lower respiratory tract infection caused by the opportunistic Gram-negative pathogen *Pseudomonas aeruginosa* in individuals with the genetic disorder cystic fibrosis In this population, defective cystic fibrosis transmembrane conductance regulator (CFTR) function results in dehydrated, viscous airway secretions and impaired mucociliary clearance, creating an ideal niche for rapid bacterial proliferation ...
- cysticfibrosisnewstoday.com
Clinically, it manifests as an acute pulmonary exacerbation marked by sudden clinical decline, increased cough, changes in sputum production or purulence, tachypnea, dyspnea, and systemic signs such as fever and weight loss Pathophysiologically, the infection induces intense neutrophilic inflammation, tissue destruction, and alveolar consolidation, which can precipitate respiratory failure and accelerate progressive irreversible loss of lung function
- cff.org
Clinically, it manifests as an acute pulmonary exacerbation marked by sudden clinical decline, increased cough, changes in sputum production or purulence, tachypnea, dyspnea, and systemic signs such as fever and weight loss
- nih.gov
Pathophysiologically, the infection induces intense neutrophilic inflammation, tissue destruction, and alveolar consolidation, which can precipitate respiratory failure and accelerate progressive irreversible loss of lung function
Personalize your experience
Follow Acute Pseudomonas aeruginosa pneumonia associated with cystic fibrosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.